Navigation Links
Ezra Van Gelder Joins Microchip Biotechnologies as Executive Vice President R&D
Date:12/4/2008

DUBLIN, Calif., Dec. 4 /PRNewswire/ -- Microchip Biotechnologies, a private company developing the Apollo next-generation fluidics platform for Life Sciences, announced today that Ezra Van Gelder has joined its team as Executive Vice President of R&D.

Ezra Van Gelder brings Microchip Biotechnologies (MBI) extensive leadership experience in research and development from the life science, medical device and semiconductor equipment industries. Prior to joining MBI, Ezra Van Gelder headed instrument and reagent development for DNA and RNA sample preparation at Arcxis Biosciences. At Molecular Dynamics, Amersham and GE Healthcare, where he was VP of Development for the West Coast, he led development for DNA sequencing and cell analysis. In the semiconductor industry Ezra Van Gelder directed the development of automated optical wafer inspection equipment at KLA Instruments and KLA-Tencor.

"The addition of Ezra Van Gelder, as Executive VP of R&D, further strengthens the world class team at MBI. Ezra brings considerable expertise in developing innovative next generation life science solutions focused on end users and implementing product development processes and ISO 13485," said Dr. Stevan Jovanovich, President and CEO of Microchip Biotechnologies. "Ezra's R&D leadership and experience will accelerate the full integration of sample preparation and analysis on MBI's Apollo platform."

"I have spent much of my career working on separate reagent and analytical instrumentation systems, so I am now relishing the prospect of working with a platform that can genuinely integrate macro and microfluidics to provide much needed, complete sample-to-answer solutions," said Ezra Van Gelder. "The Apollo platform, along with the exceptional group at MBI, will bring new capabilities to life sciences, diagnostics and compact field portable devices for life science applications."

Ezra Van Gel
'/>"/>

SOURCE Microchip Biotechnologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Richard Greco Joins Mediware Board
2. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
3. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
4. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
5. Nick Childs Joins Grey New York as Director of Content Development
6. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
7. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
8. NASN Joins Partnership to Fight Chronic Disease
9. AstraZeneca Joins Local Walking Movement
10. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
11. Fund Manager Joins Board of GSI Securitization Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... 26, 2014 Pentec Health, Inc. number ... state of Pennsylvania for 2014. The awards program, created ... of its kind in the country. The program is ... Department of Community and Economic Development, the Pennsylvania State ... the Central Penn Business Journal. , Charlie ...
(Date:12/26/2014)... 26, 2014 Parker & Sons, ... best in heating, cooling and plumbing contractor services ... emergency services in 2014 with regard to air-conditioning ... Arizona is known for its incredibly hot summers. ... the intricacies and details of a wide variety ...
(Date:12/25/2014)... 26, 2014 This is a professional ... global Sterilizers industry with a focus on the Chinese ... status of the Sterilizers manufacturers and is a valuable ... interested in the industry. This report provides a basic ... manufacturing technology. In this part, the report presents the ...
(Date:12/25/2014)... 26, 2014 The report “Nintedanib ... 2023” focuses on the current treatment landscape, unmet ... colorectal cancer market. Stivarga is a drug which ... rectal cancer. Boehringer Ingelheim is developing nintedanib (BIBF-1120), ... of refractory CRC in the US, Europe, and ...
(Date:12/25/2014)... Product liability lawsuits filed in the ... http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal court, ... in the U.S. District Court, Northern District of Ohio ... conference on January 7, 2015, at the Paul G. ... Palm Beach, Florida. The Conference is scheduled to begin ...
Breaking Medicine News(10 mins):Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3
... The outlook for patients with breast cancer is determined in ... other sites in the body. A team of researchers, led ... de Compostela, Spain, has now identified in a subset of ... of tumors at distant sites; a finding that they hope ...
... MONDAY, Nov. 8 (HealthDay News) -- Among certain patients ... anticlotting medication called Pradaxa (dabigatran) appears to be as ... second stroke, new German research reveals. Specifically, the ... of a second stroke as effectively as warfarin among ...
... International experts and scientists will present new ... of stockpiled drugs to identifying unlabeled substances in ... the 2010 International Pharmaceutical Federation (FIP) Pharmaceutical Sciences ... Association of Pharmaceutical Scientists (AAPS) Annual Meeting and ...
... Mozes HealthDay Reporter , SUNDAY, Nov. 7 (HealthDay ... as rates of the painful and sometimes disabling arthritic condition ... report that by 2008, an estimated 8.3 million Americans were ... U.S. adult population. That,s a substantial rise from the 2.7 ...
... to date of the Arthritis Foundation,s Tai Chi program, ... of well-being. Their ability to reach while maintaining ... lead author, associate professor in the University of North ... member of UNC,s Thurston Arthritis Research Center. "Our ...
... can be used to save the lives of mothers ... children, reaching underserved populations in remote areas., More advanced ... on patients, keeping records, improving diagnosis and treatment in ... practitioners and specialists for guidance., "With mobile technologies for ...
Cached Medicine News:Health News:New Drug, Pradaxa, May Prevent Second Stroke in Certain Heart Patients 2Health News:New Drug, Pradaxa, May Prevent Second Stroke in Certain Heart Patients 3Health News:Painful Gout on the Rise in U.S. 2Health News:Painful Gout on the Rise in U.S. 3Health News:Painful Gout on the Rise in U.S. 4Health News:Study: Tai Chi relieves arthritis pain, improves reach, balance, well-being 2Health News:Cell phones help save the lives of mothers, infants and children 2Health News:Cell phones help save the lives of mothers, infants and children 3Health News:Cell phones help save the lives of mothers, infants and children 4Health News:Cell phones help save the lives of mothers, infants and children 5Health News:Cell phones help save the lives of mothers, infants and children 6
(Date:12/24/2014)... Dec. 24, 2014 /PRNewswire/  -- Tianyin Pharmaceutical Inc. ... company that specializes in the patented biopharmaceutical, modernized ... pharmaceutical ingredients (API) released unaudited preliminary financial results ... Fiscal Year 2015 Ended September 30, ... million compared with $14.7 million in 1Q14 with ...
(Date:12/24/2014)... , Dec. 24, 2014  Conkwest, Inc., ... developing the proprietary Natural Killer (NK) cell-line platform, ... Dr. Patrick Soon-Shiong , NantWorks founder, physician ... definitive agreement to purchase approximately $48 million of ... with the investment, he will be named Co-Chairman ...
(Date:12/24/2014)... , Dec. 23, 2014 PuraMed BioScience®, Inc., ... over-the-counter (OTC) medicinal and healthcare products, announced it received ... H, a hemp-based, advanced headache relief product, for planned ... Colorado , Washington State ... With the MigraPure H Advanced headache relief gel ...
Breaking Medicine Technology:TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3
... MOUNTAIN VIEW, Calif., March 7, 2011 IRIDEX Corporation (Nasdaq: ... to make an investor presentation at the ROTH 23rd Annual ... pm Pacific Time.  The conference is being held March 13-16 ... The presentation will be accessible by live webcast ...
... Grifols, a global healthcare company and biopharmaceutical manufacturer ... established an Expert Advisory Council in Transfusion Medicine drawing ... from across the globe.  The role of the Expert ... to Grifols, own transfusion medicine research and development activities. ...
Cached Medicine Technology:Grifols Establishes Expert Advisory Council in Transfusion Medicine 2Grifols Establishes Expert Advisory Council in Transfusion Medicine 3
... The VISUCAM non-mydriatic ... quality and simplicity of ... big enough to set ... photography, it features a ...
... Afinion HbA1c test and the ... you reliable facts conveniently available ... them. Advising the patient can ... The HbA1c Test Cartridge contains ...
An aid for advancing a pacemaker lead through the subcutaneous tissue of the chest wall to the pacemaker pocket....
The ARK-730A initiates automatic measurement at the optimum measurement point. The ARK-730A maintains fogging throughout multiple measurements, saving total examination time....
Medicine Products: